Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,712.00
Bid: 1,712.00
Ask: 1,716.00
Change: 2.00 (0.12%)
Spread: 4.00 (0.234%)
Open: 1,720.00
High: 1,740.00
Low: 1,700.00
Prev. Close: 1,710.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Hochschild, Wizz Air, Clipper Logistics Execs Sell

Fri, 26th Feb 2021 16:23

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News:

----------

Wizz Air Holdings PLC - Budapest-based central and eastern Europe-focused budget airline - Three senior executives sell GBP6.8 million in shares. Chief Executive Officer Jozsef Varadi sells 120,000 shares via Vaxco Holdings Ltd at GBP53.17 on Wednesday. Chief Corporate Officer Marion Geoffroy sells 2,000 shares at GBP53.74, also on Wednesday. Chief Commercial Officer George Michalopoulos sells 5,000 shares at GBP52.99 on Thursday.

----------

Hochschild Mining PLC - silver and gold mines in Peru and Argentina - CEO Ignacio Bustamante sells 577,455 shares at USD2.98 to USD3.18, worth USD1.8 million, on Thursday last week to Wednesday this week. Hochschild says the share sales are to meet personal tax liabilities, and Bustamante says he has no plans to make more share sales for at least 12 months.

----------

Clipper Logistics PLC - Leeds, England-based logistics firm - Roger Peel, subsidiary managing director, sells 244,889 shares at GBP5.80, worth GBP1.4 million, on Friday. The share sale comes after Clipper on Thursday says it won two major new contracts, with retailers River Island Clothing Ltd and Mountain Warehouse Ltd. The stock closed up 7.8% on Thursday.

----------

Reckitt Benckiser Group PLC - Slough, Berkshire-based consumer health and hygiene products - Harold van den Broek, president of Hygiene division, and associate Elizabeth Hunnekens, buy 24,000 shares in total at average GBP59.65, worth GBP1.4 million, on Wednesday. Reckitt reported annual results on Wednesday, with a swing to profit in 2020 led by a 16% jump in sales in the Hygiene division, due to Covid-19.

----------

Games Workshop Group PLC - Nottingham-based miniature wargames manufacturer and retailer - Wife of Non-Executive Director Nick Donaldson sells 8,000 shares at GBP97.21, worth GBP777,677, on Thursday.

----------

boohoo Group PLC - Manchester-based online fashion retailer - Non-Executive Director Iain McDonald buys 100,000 shares at 334.77p, worth GBP334,770, on Friday. Now has 621,336 shares.

----------

Edinburgh Investment Trust PLC - invests primarily in UK equities - Non-Executive Director Patrick Edwardson and Anna Edwardson buy 60,000 shares in total at at 552.21 pence and 551.23p, together worth GBP331,669, on Tuesday. James de Uphaugh, the trust's manager and chief investment officer of Majedie Asset Management, buys 3,157 shares at 562.50p, worth GBP17,758, on Wednesday. Senior Independent Director Victoria Hastings buys 4,000 shares 568.00p, worth GBP22,720, on Thursday.

----------

Genus PLC - Basingstoke, Hampshire-based animal genetics - Catherine Ferguson, wife of Chair Iain Ferguson, buys 1,500 shares at average 4,850.77p, worth GBP72,762, on Thursday.

----------

Fulcrum Utility Services Ltd - Sheffield-based multi-utility infrastructure and services provider - Dominic Lavelle, newly appointed on Monday as senior independent non-executive director, buys 50,000 shares at 36.35p, worth GBP18,175, on Thursday. The shares are his only holding. Lavelle was chief financial officer of SDL PLC, a language services firm that merged with RWS Holdings PLC back in November.

----------

NB Private Equity Partners Ltd - closed end private equity fund - Director John Falla buys 2,000 shares at 1,195.00p, worth GBP23,900, on Thursday. Now has 8,000 shares

----------

HSBC Holdings PLC - London-based bank - Non-Executive Director Irene Less buys 3,096 shares at HKD48.30, worth HKD149,537, about GBP13,804, on Thursday.

----------

UDG Healthcare PLC - Dublin-based healthcare services provider - Non-Executive Director Myles Lee and spouse Louise Lee buy 5,000 shares at GBP7.72, worth GBP38,600, on Wednesday.

----------

Morses Club PLC - Batley, West Yorkshire-based home collected credit provider and online loans - CFO Graeme Campbell buys 40,000 at 65.77p, worth GBP26,308, on Thursday. The purchase is his only holding.

----------

TheWorks.co.uk PLC - Birmingham-based gifts and stationery retailer - Non-executive directors Harry Morley and Catherine Glickman buy 24,493 shares on Wednesday and 45,432 shares on Thursday, respectively. The purchases, at GBP0.43 and GBP0.44, are worth GBP30,382 in total. Morley now has 100,000 shares and Glickman 77,244.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
12 Aug 2016 07:06

Genus suffers legal setback Stateside

(ShareCast News) - Genus suffered a legal setback Stateside as a US judge handed down a series of verdicts against the animal genetics specialist. The US District Court for Wisconsin ruled that two of Genus rival ST´s patents were valid and had been infringed and that ABS, a unit of Genus, had mater

Read more
11 Aug 2016 10:01

Genus and Sexing still battling over semen

(ShareCast News) - Animal genetics company Genus announced the first jury verdicts in its antitrust litigation against Inguran, operating as Sexing Technologies, relating to ABS's 'Genus Sexed Semen' processing technology. The FTSE 250 firm said that at the trial in the US District Court for the Wes

Read more
11 Aug 2016 07:45

Genus Says US Court Finds Against Inguran But Sees No Injury To Genus

Read more
4 Aug 2016 11:59

Thursday broker round-up

(ShareCast News) - Next: Goldman Sachs reiterates sell with a target price of 4800p. Standard Chartered: JP Morgan maintains overweight with a 800p target. Shire: JP Morgan reiterates overweight with a 6300p target. Genus: HSBC stays at buy with a 2200p target. Nichols: UBS keeps at buy with a ta

Read more
4 Jul 2016 08:37

BROKER RATINGS SUMMARY: Liberum Downgrades Property Stocks

Read more
4 Jul 2016 08:21

CORRECT (01/07): WINNERS & LOSERS SUMMARY

Read more
1 Jul 2016 15:58

LONDON MARKET CLOSE: Stocks Close Week After Brexit Vote On A High

Read more
1 Jul 2016 11:09

LONDON MARKET MIDDAY: Carney Boosts Stocks As easyJet Eyes Own Brexit

Read more
1 Jul 2016 09:11

WINNERS & LOSERS SUMMARY: Dignity And Genus Benefit From Upgrades

Read more
1 Jul 2016 08:51

BROKER RATINGS SUMMARY: Berenberg - Buy Dignity; Liberum - Buy Genus

Read more
1 Jul 2016 07:24

LONDON BRIEFING: Carney Lifts Brexit Blues With Policy Assurance

Read more
20 Jun 2016 09:25

ITV, Wolseley are Liberum's top-picks in case of Bremain, Brexit

(ShareCast News) - Depending on whether the UK finally decided to 'Remain' or 'Leave' then different London-listed securities were likelier to 'outperform' their respective sectors, Liberum said. The broker's 'top-picks' under a 'Remain', 'Leave' and 'Either way' scenario were, ITV, Wolseley and Bal

Read more
26 May 2016 14:30

FTSE 250 movers: Ibstock retreats as Pets at Home accelerates

(ShareCast News) - The FTSE 250 slipped further into the red late as Thursday wore on, despite having peeped its head above water around midday. Leading the index lower, shares in Ibstock subsided as the brick maker reported a slow start to the year for its UK clay business had lasted four months b

Read more
18 May 2016 09:49

Genus announces collaboration with Caribou Biosciences

(ShareCast News) - Genus announced a strategic collaboration with US-based Caribou Biosciences that will give the London-listed animal genetics group exclusive license to Caribou's gene editing technology platform. Caribou's CRISPR-Cas9 technology accurately targets and cuts DNA to produce precise a

Read more
18 May 2016 07:01

Genus Signs Gene Editing Platform Deal With Caribou Biosciences

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.